The placebo response: neurobiological and clinical issues of neurological relevance

Progress in Brain Research

Volumn 175, Issue , 2009, Pages 283-294

  Pollo, Antonella ^a   Benedetti, Fabrizio ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

conditioning; expectation; neurotherapy; pain; placebo

Indexed keywords

DOPAMINE;

ANTINOCICEPTION; CLINICAL RESEARCH; COGNITION; CONDITIONING; CORPUS STRIATUM; DEPRESSION; DOPAMINE RELEASE; EXPECTATION; HUMAN; MOTOR PERFORMANCE; NEUROBIOLOGY; NEUROCHEMISTRY; NEUROPHARMACOLOGY; PAIN; PARKINSON DISEASE; PLACEBO EFFECT; PRIORITY JOURNAL; REFLEX; REVIEW; REWARD;

ANIMALS; BRAIN; DEPRESSION; HUMANS; PAIN; PARKINSON DISEASE; PLACEBO EFFECT; PLACEBOS; RESEARCH DESIGN;

EID: 67849094627     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(09)17520-9     Document Type: Review

References (102)

1. Ader R. The role of conditioning in pharmacotherapy. In: Harrington A. (Ed). The placebo effect: an interdisciplinary exploration (1997), Harvard University Press, Cambridge, MA 138-165
2. Ader R. Conditioned immunomodulation: research needs and directions. Brain, Behavior, and Immunity 17 (2003) S51-S57
3. Ader R., and Cohen N. Behaviorally conditioned immunosuppression and murine systemic lupus erythematosus. Science 215 (1982) 1534-1536
4. Amanzio M., and Benedetti F. Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific sub-systems. Journal of Neuroscience 19 (1999) 484-494
5. Amanzio M., Pollo A., Maggi G., and Benedetti F. Response variability and to analgesics: a role for non-specific activation of endogenous opioids. Pain 90 (2001) 205-215
6. Barrett B., Muller D., Rakel D., Rabago D., Marchand L., and Scheder J. Placebo, meaning and health. Perspectives in Biology and Medicine 49 (2006) 178-198
7. Bausell R.B., Lao L., Bergman S., Lee W.L., and Berman B.M. Is acupuncture analgesia an expectancy effect?. Evaluation and the Health Professions 28 (2005) 9-26
8. Benedetti F. The opposite effects of the opiate antagonist naloxone and the cholecystokinin antagonist proglumide on placebo analgesia. Pain 64 (1996) 535-543
9. Benedetti F. How the doctor's words affect the patient's brain. Evaluation and the Health Professions 25 (2002) 369-386
10. Benedetti F. Placebo and endogenous mechanisms of analgesia. Handbook of Experimental Pharmacology 177 (2007) 393-413
11. Benedetti F. Mechanisms of placebo and placebo-related effects across diseases and treatments. Annual Review of Pharmacology and Toxicology 48 (2008) 33-60
12. Benedetti F. TPlacebo effects: understanding the mechanisms in health and disease (2008), Oxford University Press, Oxford University Press
13. Benedetti F., Amanzio M., Baldi S., Casadio C., and Maggi G. Inducing placebo respiratory depressant responses in humans via opioid receptors. European Journal of Neuroscience 11 (1999) 625-631
14. Benedetti F., Amanzio M., and Maggi G. Potentiation of placebo analgesia by proglumide. Lancet 346 (1995) 1231
15. Benedetti F., Arduino C., and Amanzio M. Somatotopic activation of opioid systems by target-directed expectations of analgesia. Journal of Neuroscience 19 (1999) 3639-3648
16. Benedetti F., Arduino C., Costa S., Vighetti S., Tarenzi L., Rainero I., et al. Loss of expectation-related mechanisms in Alzheimer's disease makes analgesic therapies less effective. Pain 121 (2006) 133-144
17. Benedetti F., Colloca L., Torre E., Lanotte M., Melcarne A., Pesare M., et al. Placebo-responsive Parkinson patients show decreased activity in single neurons of subthalamic nucleus. Nature Neuroscience 7 (2004) 587-588
18. Benedetti F., Mayberg H.S., Wager T.D., Stolher C.S., and Zubieta J.K. Neurobiological mechanisms of the placebo effect. Journal of Neuroscience 25 (2005) 10390-10402
19. Benedetti F., Pollo A., Lopiano L., Lanotte M., Vighetti S., and Rainero I. Conscious expectation and unconscious conditioning in analgesic, motor and hormonal placebo/nocebo responses. Journal of Neuroscience 23 (2003) 4315-4323
20. Bingel U., Lorenz J., Schoell E., Weiller C., and Büchel C. Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network. Pain 120 (2006) 8-15
21. Brody H. The placebo response (2000), Harper Collins, New York
22. Cavanna A.E., Strigaro G., and Monaco F. Brain mechanisms underlying the placebo effect in neurological disorders. Functional Neurology 22 (2007) 89-94
23. Colloca L., and Benedetti F. Placebos and painkillers: is mind as real as matter?. Nature Reviews. Neuroscience 6 (2005) 545-552
24. Colloca L., and Benedetti F. How prior experience shapes placebo analgesia. Pain 124 (2006) 126-133
25. Colloca L., Benedetti F., and Porro C.A. Experimental designs and brain mapping approaches for studying the placebo analgesic effect. European Journal of Applied Physiology 102 (2008) 371-380
26. Colloca L., Lopiano L., Lanotte M., and Benedetti F. Overt versus covert treatment for pain, anxiety, and Parkinson's disease. Lancet Neurology 3 (2004) 679-684
27. Colloca L., Sigaudo M., and Benedetti F. The role of learning in nocebo and placebo effects. Pain 136 (2008) 211-218
28. Colloca L., Tinazzi M., Recchia S., Le Pera D., Fiaschi A., Benedetti F., et al. Learning potentiates neurophysiological and behavioral placebo analgesic responses. Pain 139 (2008) 306-314
29. De Craen A., Tijssen J.G.P., de Gans J., and Kleijnen J. Placebo effect in the acute treatment of migraine: subcutaneous placebos are better than oral placebos. Journal of Neurology 247 (2000) 183-188
30. de la Fuente-Fernández R., Phillips A.G., Zamburlini M., Sossi V., Calne D.B., and Stoessl A.J. Dopamine release in human ventral striatum and expectation of reward. Behavioural Brain Research 136 (2002) 359-363
31. de la Fuente-Fernández R., Ruth T.J., Sossi V., Schulzer M., Calne D.B., and Stoessl A.J. Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science 293 (2001) 1164-1166
32. de la Fuente-Fernández R., Schulzer M., and Stoessl A.J. The placebo effect in neurological disorders. Lancet Neurology 1 (2002) 85-91
33. de la Fuente-Fernández R., Schulzer M., and Stoessl A.J. Placebo mechanisms and reward circuitry: clues from Parkinson's disease. Biological Psychiatry 56 (2004) 67-71
34. de la Fuente-Fernández R., and Stoessl A.J. The placebo effect in Parkinson's disease. Trends in Neurosciences 6 (2002) 302-306
35. Di Blasi Z., Harkness E., Ernst E., Georgiou A., and Kleijnen J. Influence of context effect on health outcomes: a systematic review. Lancet 357 (2001) 757-762
36. Enck P., Benedetti F., and Schedlowski M. New insights into the placebo and nocebo responses. Neuron 59 (2008) 195-206
37. Fields H. State-dependent opioid control of pain. Nature Reviews. Neuroscience 5 (2004) 565-575
38. Fields H.L., and Levine J.D. Placebo analgesia-a role for endorphins?. Trends in Neurosciences 7 (1984) 271-273
39. Finniss D.G., and Benedetti F. Mechanisms of the placebo response and their impact on clinical trials and clinical practice. Pain 114 (2005) 3-6
40. Giang D.W., Goodman A.D., Schiffer R.B., Mattson D.H., Petrie M., Cohen N., et al. Conditioning of cyclophosphamide-induced leukopenia in humans. Journal of Neuropsychiatry and Clinical Neurosciences 8 (1996) 194-201
41. Goebel M.U., Trebst A.E., Steiner J., Xie Y.F., Exton M.S., Frede S., et al. Behavioral conditioning of immunosuppression is possible in humans. FASEB Journal 16 (2002) 1869-1873
42. Goffaux P., Redmond W.J., Rainville P., and Marchand S. Descending analgesia-when the spine echoes what the brain expects. Pain 130 (2007) 137-143
43. Gospic K., Gunnarsson T., Fransson P., Ingvar M., Lindefors N., and Petrovic P. Emotional perception modulated by an opioid and a cholecystokinin agonist. Psychopharmacology 197 (2008) 295-307
44. Gracely R.H., Dubner R., Wolskee P.J., and Deeter W.R. Placebo and naloxone can alter post-surgical pain by separate mechanisms. Nature 306 (1983) 264-265
45. Herrnstein R.J. Placebo effect in the rat. Science 138 (1962) 677-678
46. Hrobjartsson A., and Gotzsche P.C. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. The New England Journal of Medicine 344 (2001) 1594-1602
47. Kaptchuk T.J., Kelley J.M., Deykin A., Wayne P.M., Lasagna L.C., Epstein I.O., et al. Do "placebo responders"exist?. Contemporary Clinical Trials 29 (2008) 587-595
48. Kaptchuk T.J., Stason W.B., Davis R.B., Legedza A.T.R., Schnyer R.N., Kerr C.E., et al. Sham device v. inert pill: randomized controlled trial of two placebo treatments. BMJ 332 (2006) 391-397
49. Keltner J.R., Furst A., Fan C., Redfern R., Inglis B., and Fields H.L. Isolating the modulatory effect of expectation on pain transmission: a functional magnetic imaging study. Journal of Neuroscience 26 (2006) 4437-4443
50. Kemeny M.E., Rosenwasser L.J., Panettieri R.A., Rose R.M., Berg-Smith S.M., and Kline J.N. Placebo response in asthma: a robust and objective phenomenon. Journal of Allergy and Clinical Immunology 119 (2007) 1375-1381
51. Kirsch I. How expectancies shape experience (1999), American Psychological Association, Washington, DC
52. Kong J., Gollub R.L., Rosman I.S., Webb J.M., Vangel M.G., Kirsch I., et al. Brain activity associated with expectancy-enhanced placebo analgesia as measured by functional magnetic resonance imaging. Journal of Neuroscience 26 (2006) 381-388
53. Kong J., Kaptchuk T.J., Polich G., Kirsch I., and Gollub R.L. Placebo analgesia: findings from brain imaging studies and emerging hypothesis. Review of Neuroscience 18 (2007) 173-190
54. Leuchter A.F., Cook I.A., Witte E.A., Morgan M., and Abrams M. Changes in brain function of depressed subjects during treatment with placebo. American Journal of Psychiatry 159 (2002) 122-129
55. Levine J.D., Gordon N.C., and Fields H.L. The mechanisms of placebo analgesia. Lancet 2 (1978) 654-657
56. Lichtenberg P., Heresco-Levy U., and Nitzan U. The ethics of the placebo in clinical practice. Journal of Medical Ethics 30 (2004) 551-554
57. Lidstone S.C., and Stoessl A.J. Understanding the placebo effect: contributions from neuroimaging. Molecular Imaging and Biology 9 (2007) 176-185
58. Linde K., Witt C.M., Streng A., Weidenhammer W., Wagenpfeil S., Brinkhaus B., et al. The impact of patient expectations on outcomes in four randomized controlled trials of acupuncture in patients with chronic pain. Pain 128 (2007) 264-271
59. Lipman J.J., Miller B.E., Mays K.S., Miller M.N., North W.C., and Byrne W.L. Peak B endorphin concentration in cerebrospinal fluid: reduced in chronic pain patients and increased during the placebo response. Psychopharmacology 102 (1990) 112-116
60. Lorenz J., Hauch M., Paur R.C., Nakamura Y., Zimmermann R., Bromm B., et al. Cortical correlates of false expectations during pain intensity judgments-a possible manifestation of placebo/nocebo cognitions. Brain, Behavior, and Immunity 19 (2005) 283-295
61. Matre D., Casey K.L., and Knardahl S. Placebo-induced changes in spinal cord pain processing. Journal of Neuroscience 26 (2006) 559-563
62. Mayberg H.S., Silva J.A., Brannan S.K., Tekell J.L., Mahurin R.K., McGinnis S., et al. The functional neuroanatomy of the placebo effect. American Journal of Psychiatry 159 (2002) 728-737
63. McRae C., Cherin E., Yamazaki G.T., Diem G., Vo A.H., Russel D., et al. Effects of perceived treatment on quality of life and medical outcomes in a double-blind placebo surgery trial. Archives of General Psychiatry 61 (2004) 412-420
64. Mercado R., Constantoyannis C., Mandat T., Kumar A., Schulzer M., Stoessl A.J., et al. Expectation and the placebo effect in Parkinson's disease patients with subthalamic nucleus deep brain stimulation. Movement Disorders 21 (2006) 1457-1461
65. Millan M.J. Descending control of pain. Progress in Neurobiology 66 (2002) 355-474
66. Miller F.G., and Kaptchuk T.J. The power of context: reconceptualizing the placebo effect. Journal of the Royal Society of Medicine 101 (2008) 222-225
67. Montgomery G.H., and Kirsch I. Classical conditioning and the placebo effect. Pain 72 (1997) 107-113
68. Nitzan U., and Lichtenberg P. Questionnaire survey on use of placebo. BMJ 329 (2008) 944-946
69. Noble F., and Roques B.P. The role of CCK2 receptors in the homeostasis of the opioid system. Drugs of Today 39 (2003) 897-908
70. Oken B.S. Placebo effects: clinical aspects and neurobiology. Brain 131 (2008) 2812-2823
71. Pacheco-López G., Engler H., Niemi M.B., and Schedlowski M. Expectations and associations that heal: immunomodulatory placebo effects and its neurobiology. Brain, Behavior, and Immunity 20 (2006) 430-446
72. Petrovic P., Kalso E., Petersson K.M., and Ingvar M. Placebo and opioid analgesia-imaging a shared neuronal network. Science 295 (2002) 1737-1740
73. Pollo A., Amanzio M., Arslanian A., Casadio C., Maggi G., and Benedetti F. Response expectancies in placebo analgesia and their clinical relevance. Pain 93 (2001) 77-83
74. Pollo A., and Benedetti F. Placebo response: relevance to the rheumatic diseases. Rheumatic Disease Clinics of North America 34 (2008) 331-349
75. Pollo A., Carlino E., and Benedetti F. The top-down influence of ergogenic placebos on muscle work and fatigue. European Journal of Neuroscience 28 (2008) 379-388
76. Pollo A., Torre E., Lopiano L., Rizzone M., Lanotte M., Cavanna A., et al. Expectation modulates the response to subthalamic nucleus stimulation in Parkinsonian patients. Neuroreport 13 (2002) 1383-1386
77. Pollo A., Vighetti S., Rainero I., and Benedetti F. Placebo analgesia and the heart. Pain 102 (2003) 125-133
78. Price D.D., Finniss D.G., and Benedetti F. A comprehensive review of the placebo effects: recent advances and current thought. Annual Review of Psychology 59 (2008) 565-590
79. Price D.D., Milling L.S., Kirsch I., Duff A., Montgomery G.H., and Nicholls S.S. An analysis of factors that contribute to the magnitude of placebo analgesia in an experimental paradigm. Pain 83 (1999) 147-156
80. Rainville P., and Duncan G.H. Functional brain imaging of placebo analgesia: methodological challenges and recommendations. Pain 121 (2006) 177-180
81. Reiss S. Pavlovian conditioning and human fear: an expectancy model. Behavior Therapy 11 (1980) 380-396
82. Rescorla R.A. Pavlovian conditioning: it is not what you think it is. American Psychologist 43 (1988) 151-160
83. Riether C., Doenlen R., Pacheco-López G., Niemi M.B., Engler A., Engler H., et al. Behavioural conditioning of immune functions: how the CNS controls peripheral immune responses by evoking associative learning processes. Review of Neuroscience 19 (2008) 1-17
84. Scott D.J., Stoher C.S., Egnatuk C.M., Wang H., Koeppe R.A., and Zubieta J.K. Individual differences in reward responding explains placebo-induced expectations and effects. Neuron 55 (2007) 325-336
85. Scott D.J., Stoher C.S., Egnatuk C.M., Wang H., Koeppe R.A., and Zubieta J.K. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Archives of General Psychiatry 65 (2008) 220-231
86. Sherman R., and Hickner J. Academic physicians use placebos in clinical practice and believe in the mind-body connection. Journal of General Internal Medicine 23 (2007) 7-10
87. Siegel S. Explanatory mechanisms for placebo effects: Pavlovian conditioning. In: Guess H.A., Kleinman A., Kusek J.W., and Engel L.W. (Eds). The science of the placebo: toward an interdisciplinary research agenda (2002), BMJ Books, London 133-157
88. St Clair Gibson A., Lambert E.V., Rauch L.H., Tucker R., Baden D.A., Foster C., et al. The role of information processing between the brain and peripheral physiological systems in pacing and perception of effort. Sports Medicine 36 (2006) 705-722
89. Strafella A.P., Ko J.H., and Monchi O. Therapeutic application of transcranial magnetic stimulation in Parkinson's disease: the contribution of expectation. Neuroimage 31 (2006) 1666-1672
90. Thorn B. Commentaries on the placebo concept in psychotherapy. Journal of Clinical Psychology 63 (2007) 371-372
91. Vase L., Riley III J.L., and Price D.D. A comparison of placebo effects in clinical analgesic trials versus studies of placebo analgesia. Pain 99 (2002) 443-452
92. Vase L., Robinson M.E., Verne G.N., and Price D.D. The contribution of suggestion, desire, and expectation to placebo effects in irritable bowel syndrome patients. An empirical investigation. Pain 105 (2003) 17-25
93. Vase L., Robinson M.E., Verne G.N., and Price D.D. Increased placebo analgesia over timein irritable bowel syndrome (IBS) patients is associated with desire and expectation but not endogenous opioid mechanisms. Pain 115 (2005) 338-347
94. Voudouris N.J., Peck C.L., and Coleman G. Conditioned response models of placebo phenomena: further support. Pain 38 (1989) 109-116
95. Voudouris N.J., Peck C.L., and Coleman G. The role of conditioning and verbal expectancy in the placebo response. Pain 43 (1990) 121-128
96. Wager T.D., Matre D., and Casey K.L. Placebo effects in laser-evoked pain potentials. Brain, Behavior, and Immunity 20 (2006) 219-230
97. Wager T.D., Rilling J.K., Smith E.E., Sokolik A., Casey K.L., Davidson R.J., et al. Placebo-induced changes in fMRI in the anticipation and experience of pain. Science 303 (2004) 1162-1166
98. Walsch B.T., Seidman S.N., Sysko R., and Gould M. Placebo response in studies of major depression: variable, substantial, and growing. JAMA 287 (2002) 1840-1847
99. Watson A., El-Dereby W., Vogt B.A., and Jones A.K. Placebo analgesia is not due to compliance or habituation: EEG and behavioural evidence. Neuroreport 18 (2007) 771-775
100. Wikramasekera I. A conditioned response model of the placebo effect: predictions of the model. In: White L., Tursky B., and Schwartz G.E. (Eds). Placebo: theory, research and mechanisms (1985), Guilford Press, New York
101. Zubieta J.K., Bueller J.A., Jackson L.R., Scott D.J., Xu Y., Koeppe R.A., et al. Placebo effects mediated by endogenous opioid activity on μ-opioid receptors. Journal of Neuroscience 25 (2005) 7754-7762
102. Zubieta J.K., Smith Y.R., Bueller J.A., Xu Y., Kilbourn M.R., Jewett D.M., et al. Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science 293 (2001) 311-315